FDA Accepts Sol-Gel's IND Application For Rosacea
Published: 11-Nov-2009
Company to initiate Phase II studies with DER45-EV Gel
FDA has acknowledged receipt of Sol-Gel Technologies' (Sol-Gel) Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. The IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.
DER45-EV Gel is a topical product based on Sol-Gel’s patented drug delivery system that is designed to enhance the efficacy, safety and stability of topical drugs. Sol-Gel’s technology does so by encapsulating the active ingredients in an inert, clear-silica microcapsule shell and by releasing the ingredients in a time-controlled manner.
Stanley Shapiro, head of skin care science & technology at Sol-Gel, said: “As Sol-Gel’s microcapsulation forms a protective barrier between the drug and the skin, we expect it to reduce irritation when applied to the relatively sensitive skin of rosacea patients.”
Daniela Mavor, senior vice president of business development at Sol-Gel, said: “Comparative clinical studies performed in the treatment of acne, presented at the 10th International Congress of Dermatology in Prague, May 20-23, 2009, confirmed that the Sol-Gel drug delivery technology provides improved efficacy, when compared to a marketed topical formulation. Using our core technology, we also hope to achieve a greater therapeutic window in the treatment of rosacea.”
Network Sites

Suppliers To This Sector
Browse A-Z
ADAPT Localization
The Translation and Localization Specialists ...
Adis
Independently Evaluated Drug Information ...
Aris Global
Integrated Software Solutions and Services for Life Sciences ...
Axiom Real Time Metrics
EDC Solutions ...
BioClinica
Global Clinical Trial Solutions. Real-World Results ...
BIOQUELL
Specialist Providers of Bio-decontamination Equipment and Services ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully